全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Revacept: Collagen GP VI receptor inhibitor, a new & a formidable target for antiplatelet action

DOI: 10.5455/2319-2003.ijbcp20130624

Keywords: Platelet adhesion , Revacept , Collagen GP VI receptor inhibitor

Full-Text   Cite this paper   Add to My Lib

Abstract:

Antiplatelet drugs play an important role in the prevention as well as treatment of cardiovascular diseases like coronary artery disease and stroke. Many of the currently available antiplatelet drugs face limitations due to safety and efficacy issues. A new antiplatelet drug, revacept i.e. a collagen receptor antagonist, has been shown to reduce platelet adhesion by blocking GP VI-dependent pathways without increasing the risk of bleeding complications and without affecting the general hemostasis. [Int J Basic Clin Pharmacol 2013; 2(3.000): 344-346]

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133